August 15, 2016
Technology
Latest News
Advertisement
Advertisement
Pharmaceutical Executive
August 12, 2016
August 12, 2016
Pharmaceutical Executive
August 11, 2016
August 11, 2016
Pharmaceutical Executive
August 09, 2016
August 09, 2016
Pharmaceutical Executive
August 05, 2016
Pharmaceutical Executive
The acquisition will add to the company's cell therapy base and potential impact in treating rare diseases.
August 04, 2016
August 1, 2016
July 28, 2016
July 27, 2016
Pharmaceutical Executive
July 26, 2016
Pharmaceutical Executive
July 22, 2016
Pharm Exec convenes a roundtable discussion with several company chief information officers (CIOs) and IMS Health to explore ways to turn the vast reams of data now being generated in the transactional tsunami of modern healthcare into truly meaningful insights for its users.
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5